Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial

Therapeutics and Clinical Risk Management

Volumn 4, Issue 1, 2008, Pages 287-290

  Chu, Hong Nü ^a,b   Shen, Mei Juan ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Amniotic fluid index; Oligohydramnios; Salvia miltiorrhiza; Therapy

Indexed keywords

GLUCOSE; SALVIA MILTIORRHIZA EXTRACT;

ABSENCE OF SIDE EFFECTS; ADULT; AMNION FLUID LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ECHOGRAPHY; FEMALE; FETUS MONITORING; HUMAN; INTERMETHOD COMPARISON; OLIGOHYDRAMNIOS; PATIENT MONITORING; PLACENTA CIRCULATION; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST;

EID: 41549139601     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Adams JD, Wang R, Yang J, et al. 2006. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med, 1:663-94.
2. Barss VA, Benacerraf BR, Frigoletto FD. 1984. Second trimester Oligohydramnios, a predictor of poor fetal outcome. Obstet Gynecol, 64:608-13.
3. Battaglia C, Artini PG, Ballestri M, et al. 1995. Hemodynamic, hematological and hemorrheological evaluation of post-term pregnancy. Acta Obstet Gynecol Scand, 74:336-40.
4. Fugh-Berman A. 2000. Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Prev Cardiol, 3:24-32.
5. Mercwe LJ, Brown LG. 1986. Fetal outcome with oligohydramnios in the second trimester. Obstet Gynecol, 67:840-9.
6. Moher D, Schulz KF, Altman DG, et al. 2001. The revised CONSORT statement for reporting randomized trials: BMC Medical Research Methodology, 1:2doi:10.1186/1471-2288-1-2.
7. Moore TR, Cayle JE. 1990. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol, 162:1168-73.
8. Moore TR, Longo J, Leopold G, et al. 1989. The reliability and predictive volume of an amniotic fluid scoring system in severe second trimester oligohydramnios. Obstet Gynecol, 73:739-15.
9. Redline RW, Pappin A. 1995. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol, 26:80-5.
10. Rutherford SE, Jeffrey PP, Smith CV, et al. 1987. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol, 70:353-6.
11. Sarno PA, Ahn OM, Brar SH, et al. 1989. Intrapartum Doppler velocimetry, amniotic fluid volume, and fetal heart rate as predictors of subsequent fetal distress. Am J Obstet Gynecol, 161:1508-14.
12. Sun J, Huang SH, Tan Benny K-H, et al. 2005. Effects of purified herbal extract of salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Science, 76:2849-60.
13. Xu M, Liu A, Cui Y, et al. 2007. Comparative study on HPLC fingerprints of Danshenin Xiangdan injections from different manufacturers. Chin J Nat Med, 5:120-6.
14. Yokozawa, T, Chung HY, Oura H, et al. 1989. Isolation of a renal function-facilitating constituent from the Oriental drug, salviae miltiorrhizae radix. Jap J Nephrology, 31:1091-9.